MCK
64
2
NRG
45
3
SYY
31
-4
TDC
63
3
FSLR
49
-3
CMG
41
3
UNP
50
2
PCG
54
-4
AMGN
39
-5
CSCO
57
3
ADT
55
5
PPL
77
2
PYPL
32
3
MUR
49
2
MKC
38
2
EQT
65
-3
AZO
48
-2
VFC
59
-2
SHW
43
-3
LOW
24
-4
MCK
64
2
NRG
45
3
SYY
31
-4
TDC
63
3
FSLR
49
-3
CMG
41
3
UNP
50
2
PCG
54
-4
AMGN
39
-5
CSCO
57
3
ADT
55
5
PPL
77
2
PYPL
32
3
MUR
49
2
MKC
38
2
EQT
65
-3
AZO
48
-2
VFC
59
-2
SHW
43
-3
LOW
24
-4
Financhill
Back

Sumitomo Pharma Co., Ltd. 10K Form

Buy
57

DNPUF
Sumitomo Pharma Co., Ltd.

Last Price:
$14.47
Seasonality Move:
-2.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DNPUF News And Ratings

See the #1 stock for the next 7 days that we like better than DNPUF

DNPUF Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $141.3M
Price / Cash Flow: 19.52
Annual Sales: $4.64
Price / Book: 3.12

Profitability

EPS (TTM): 1.87550
Net Income (TTM): $745.1M
Gross Margin: $1.5B
Return on Equity: 52.83%
Return on Assets: 14.36%

Sumitomo Pharma Co., Ltd. Earnings Forecast

Key Sumitomo Pharma Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 46 years for DNPUF is 56.51%.
  • The Selling, General & Administrative Expenses for DNPUF have been equal to 45.28% of Gross Profit Margin.
  • The Research & Development expenses have been 12.50% of Revenue.
  • The Interest Expense is 36.21% of Operating Income.
  • The Net Earning history of DNPUF is 5.93% of Total Revenues.
  • Per Share Earnings over the last 46 years have been positive in 23 years.

Sumitomo Pharma Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: DNPUF
Website: sumitomo-pharma.co.jp

Debt

Debt-to-Equity Ratio: 0.9
Current Ratio: 1.4
Quick Ratio: 0.9

Price-to-Earnings

Trailing P/E Ratio: 37.08
Forward P/E Ratio: 0

DNPUF Technical Analysis vs Fundamental Analysis

Buy
57
Sumitomo Pharma Co., Ltd. (DNPUF) is a Buy

Is Sumitomo Pharma Co., Ltd. a Buy or a Sell?